Applied DNA Sciences Inc. (APDN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Applied DNA Sciences Inc. (APDN:NASDAQ), powered by AI.

Current Price
$0.54
P/E Ratio
-0.0
Market Cap
57,533
Sector
Healthcare
What is the Applied DNA Sciences Inc. stock price forecast?

Applied DNA Sciences Inc. is currently trading at $0.54. View real-time AI analysis on Alpha Lenz.

What is Applied DNA Sciences Inc. insider trading activity?

View the latest insider trading data for Applied DNA Sciences Inc. on Alpha Lenz.

What is Applied DNA Sciences Inc.'s P/E ratio?

Applied DNA Sciences Inc.'s P/E ratio is -0.0.

Applied DNA Sciences Inc.

NASDAQ · APDN
$0.54-0.01(-0.91%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Applied DNA Sciences Inc.'s future dividend policy...
Alpha Chat Insight

Applied DNA Sciences Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -99.2%.

Ask for details

Company Overview

Applied DNA Sciences Inc. operates as a biotechnology company focused on developing and commercializing DNA-based technologies. The company’s primary function is to provide molecular tagging and authentication solutions across a variety of industries. This includes securing supply chains and enhancing product authenticity in sectors such as pharmaceuticals, textiles, and personal care products. Applied DNA Sciences employs proprietary technologies that allow for unique DNA markers to be embedded into materials, enabling precise tracking and verification throughout the production and distribution process. This enhances transparency and trust, mitigating risks associated with counterfeiting and fraud. Beyond supply chain security, the company is actively involved in advancing DNA-based solutions in the medical diagnostics field, contributing to developments in genetic analysis and forensic science. Headquartered in Stony Brook, New York, Applied DNA Sciences plays a vital role in integrating biotechnology advancements into everyday industrial applications, reinforcing the importance of traceability and reliability in global markets.

CEOMr. Clay Shorrock Esq., J.D.
SectorHealthcare
IndustryDiagnostics & Research
Employees46

Company Statistics

FY 2024

Profile

$57.53KMarket Cap
$3.43MRevenue
0.00Shares Out
46Employees

Margins

29.63%Gross
-585.69%EBITDA
-408.72%Operating
-206.57%Pre-Tax
-206.57%Net

Valuation

-0.01P/E
0.01P/B
0.02EV/Sales
0.29EV/EBITDA
-0.00P/FCF

Growth (CAGR)

-27.56%Rev 3Yr
-8.63%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-53.62%ROA
-99.23%ROE
-106.08%ROIC

Financial Health

$6.43MCash & Cash Equivalents
$-2.61MNet Debt
42.61%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Applied DNA Sciences Inc. (ticker: APDN) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 46 employees. Market cap is $57,533.

The current price is $0.544 with a P/E ratio of -0.01x and P/B of 0.01x.

ROE is -99.23% and operating margin is -408.72%. Annual revenue is $3M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Applied DNA Sciences Inc. (APDN) Stock Forecast 2026 $0.54 — Price, Financials & Analyst Targets | Alpha Lenz